We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
36 hedge funds and large institutions have $29.5M invested in scPharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
3% more funds holding
Funds holding: 35 → 36 (+1)
1.13% less ownership
Funds ownership: 43.39% → 42.26% (-1.1%)
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
38% less capital invested
Capital invested by funds: $47.3M → $29.5M (-$17.8M)
Holders
36
Holders Change
+1
Holders Change %
+2.86%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
10
Reduced
13
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$93.6K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$83.2K |
| 3 |
BlackRock
New York
|
+$33.3K |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$30.2K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$9.04K |
Top Sellers
| 1 |
AIC
AWM Investment Company
New York
|
-$265K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$259K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$252K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$212K |
| 5 |
JP Morgan Chase
New York
|
-$97.8K |
